^
    BIOMARKER:

    PD-L2 overexpression

    i
    Other names: PDCD1LG2, Programmed Cell Death 1 Ligand 2, B7 Dendritic Cell Molecule, Programmed Death Ligand 2, Butyrophilin B7-DC, PDCD1 Ligand 2, PDCD1L2, B7-DC, CD273, PD-L2, B7DC, PDL2, PD-1-Ligand 2, CD273 Antigen, PD-1 Ligand 2, BA574F11.2, Btdc




    Show legend

    Include preclinical:
    Melanoma
    Triple Negative Breast Cancer
    Prostate Cancer
    Squamous Cell Carcinoma of Head and Neck
    Acute Myelogenous Leukemia
    Colorectal Adenocarcinoma
    Endometrial Cancer
    pembrolizumab
    capecitabine
    nivolumab
    ipilimumab
    paclitaxel
    avelumab
    Immunotherapy
    PD-L1 inhibitor
    PD-L1 inhibitor + PD-L2 inhibitor